Cboe Global Markets, Inc. (BMV:CBOE)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	4,532	4,095	3,774	3,959	3,495	3,427
Revenue	4,532	4,095	3,774	3,959	3,495	3,427
Revenue Growth (YoY)	18.98%	8.51%	-4.67%	13.27%	1.98%	37.30%
Cost of Revenue	2,323	2,022	1,856	2,217	2,019	2,173
Gross Profit	2,209	2,072	1,918	1,742	1,476	1,254
Selling, General & Admin	743.3	730.4	680.8	578.5	470.8	364.2
Other Operating Expenses	26.2	26.2	28.3	31.2	19.1	17.5
Operating Expenses	893.6	889.6	867.1	776.5	657.3	540.2
Operating Income	1,315	1,183	1,051	965.2	818.8	714.1
Interest Expense	-51.4	-51.5	-62.4	-60	-48	-38.7
Interest & Investment Income	39.1	56.3	53.6	10.8	1.6	0.7
Earnings From Equity Investments	-	-	-	-	-	1.1
Other Non Operating Income (Expenses)	5.7	11	0.3	1.8	2.2	2.1
EBT Excluding Unusual Items	1,309	1,199	1,042	917.8	774.6	679.3
Merger & Restructuring Charges	-0.3	-1.3	-7.4	-19.9	-15.6	-45.2
Impairment of Goodwill	-	-	-	-460.9	-	-
Gain (Loss) on Sale of Investments	-19.8	-31.4	-1.8	-10.6	-5.6	0.4
Gain (Loss) on Sale of Assets	1	1	-	-	-	-
Asset Writedown	-17.1	-81	-	-	-	-
Other Unusual Items	0.9	-2.1	14.4	6.5	2.7	25.9
Pretax Income	1,274	1,084	1,048	432.9	756.1	660.4
Income Tax Expense	372.8	318.9	286.2	197.9	227.1	192.2
Earnings From Continuing Operations	900.7	764.9	761.4	235	529	468.2
Net Income	900.7	764.9	761.4	235	529	468.2
Preferred Dividends & Other Adjustments	4.4	3.9	3.9	0.9	1.7	1.2
Net Income to Common	896.3	761	757.5	234.1	527.3	467
Net Income Growth	16.96%	0.46%	224.00%	-55.58%	12.99%	24.89%
Shares Outstanding (Basic)	105	105	106	106	107	109
Shares Outstanding (Diluted)	105	106	106	107	107	109
Shares Change (YoY)	-0.90%	-0.66%	-0.47%	-0.47%	-1.92%	-2.24%
EPS (Basic)	8.56	7.24	7.16	2.20	4.93	4.28
EPS (Diluted)	8.52	7.21	7.13	2.19	4.92	4.27
EPS Growth	18.01%	1.12%	225.57%	-55.49%	15.22%	27.84%
Free Cash Flow	-113.1	1,040	1,031	591.3	545.8	1,411
Free Cash Flow Per Share	-1.08	9.86	9.70	5.54	5.09	12.91
Dividend Per Share	2.520	2.360	2.100	1.960	1.800	1.560
Dividend Growth	14.54%	12.38%	7.14%	8.89%	15.38%	16.42%
Gross Margin	48.74%	50.61%	50.83%	44.00%	42.24%	36.60%
Operating Margin	29.03%	28.89%	27.85%	24.38%	23.43%	20.84%
Profit Margin	19.78%	18.59%	20.07%	5.91%	15.09%	13.63%
Free Cash Flow Margin	-2.50%	25.39%	27.31%	14.94%	15.62%	41.18%
EBITDA	1,429	1,306	1,201	1,125	978.9	865.7
EBITDA Margin	31.54%	31.88%	31.81%	28.42%	28.01%	25.26%
D&A For EBITDA	113.8	122.7	149.6	159.6	160.1	151.6
EBIT	1,315	1,183	1,051	965.2	818.8	714.1
EBIT Margin	29.03%	28.89%	27.85%	24.38%	23.43%	20.84%
Effective Tax Rate	29.27%	29.42%	27.32%	45.72%	30.04%	29.10%
Revenue as Reported	4,532	4,095	3,774	3,959	3,495	3,427

Source: S&P Global Market Intelligence. Standard template. Financial Sources.